We investigated the methylation changes between the high- and low-expression groups of CBX6 and CBX7 and discovered that the methylation of CBX6 and CBX7 was considerably elevated in the bladder cancer group (Figure 7A,B). Here, CBX6 is linked to urinary bladder carcinoma.